Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2022-01-10 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
CHANGE OF COMPANY SECRETARY
Board/Management Information Classification · 100% confidence The document is an announcement from Sisram Medical Ltd regarding the resignation and appointment of the company secretary. It details changes in senior management positions, specifically the company secretary role, including biographical information about the new appointee. There is no financial data, report publication, or voting results mentioned. The content fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2022-01-10 English
POSITIVE PROFIT ALERT
Earnings Release Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement by Sisram Medical Ltd regarding preliminary unaudited financial performance for the 12 months ended December 31, 2021. It states expected significant increases in revenue and profit based on preliminary assessment of unaudited consolidated management accounts. The announcement explicitly mentions that the information has not been audited or reviewed by the auditor or audit committee and that detailed financial information will be disclosed in the annual results announcement expected before the end of March 2022. The document is relatively short (3309 characters) and serves as an initial earnings alert rather than a full financial report. It does not contain actual financial statements or detailed analysis but provides key highlights of expected financial performance. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. FY 2021
2022-01-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Share Issue/Capital Change Classification · 95% confidence The document is a monthly return report detailing movements in authorised/registered share capital and issued shares for Sisram Medical Ltd, submitted to the Hong Kong Exchanges and Clearing Limited. It includes specific data on share capital, issued shares, and confirmations related to share movements. The document is regulatory in nature, reporting share capital and share issuance movements, but it is not a full financial report, earnings release, or management discussion. It is not a proxy, AGM material, or a voting result announcement. The document fits the description of a Major Shareholding Notification or Share Issue/Capital Change. Since it reports movements in share capital and issued shares without new share issuance or repurchase, it aligns best with Share Issue/Capital Change (SHA) category, which covers announcements regarding new share issues, stock splits, or other capital changes. The document is 4663 characters long, detailed, and contains substantive data on share capital movements, not just an announcement of a report. Therefore, the classification is SHA with high confidence.
2022-01-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued share capital, convertibles, and confirmations related to securities issued by Reliance Global Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, providing detailed share capital movements and confirmations but does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a regulatory filing itself. The document fits best under the category of Regulatory Filings (RNS) as it is a compliance and disclosure document related to share capital movements and confirmations under listing rules, without being a financial report or announcement of a report.
2022-01-03 English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES IN THE COMPANY BY THE CONTROLLING SHAREHOLDER
Transaction in Own Shares Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd regarding the purchase of shares in the company by its controlling shareholder. It details the on-market purchase of shares by Ample Up Limited, a wholly-owned subsidiary of the controlling shareholder Fosun Pharma. The document does not contain financial statements, earnings data, or detailed financial analysis. It is an announcement about a transaction involving the company's own shares, specifically a share repurchase by a controlling shareholder. The document length is short (2043 characters) and it is not a report or a regulatory filing about financial results or governance changes. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS).
2021-12-29 English
Interim Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021 Interim Report' for Reliance Global Holdings Limited and contains detailed financial statements and management discussion and analysis for the six months ended 30 September 2021. It includes sections such as condensed consolidated interim financial statements, profit and loss statements, financial position, changes in equity, cash flows, and notes to the financial statements. The content is comprehensive and covers a period shorter than a full fiscal year, consistent with an interim or quarterly report. The document length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-12-29 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.